Co-Authors
This is a "connection" page, showing publications co-authored by MARK S CHAMBERS and RANDAL S WEBER.
Connection Strength
1.295
-
Cevimeline for the treatment of postirradiation xerostomia in patients with head and neck cancer. Int J Radiat Oncol Biol Phys. 2007 Jul 15; 68(4):1102-9.
Score: 0.306
-
Radiation-induced xerostomia. Head Neck. 2007 Jan; 29(1):58-63.
Score: 0.302
-
Intensity-modulated radiotherapy: is xerostomia still prevalent? Curr Oncol Rep. 2005 Mar; 7(2):131-6.
Score: 0.266
-
A phase II study of gefitinib for aggressive cutaneous squamous cell carcinoma of the head and neck. Clin Cancer Res. 2012 Mar 01; 18(5):1435-46.
Score: 0.107
-
Open-label, long-term safety study of cevimeline in the treatment of postirradiation xerostomia. Int J Radiat Oncol Biol Phys. 2007 Dec 01; 69(5):1369-76.
Score: 0.079
-
Intensity-modulated radiation therapy and xerostomia. J Calif Dent Assoc. 2006 Sep; 34(9):743-8.
Score: 0.074
-
Outcomes after definitive surgery for mandibular osteoradionecrosis. Head Neck. 2022 06; 44(6):1313-1323.
Score: 0.054
-
Head and neck surgical oncology in the time of a pandemic: Subsite-specific triage guidelines during the COVID-19 pandemic. Head Neck. 2020 06; 42(6):1194-1201.
Score: 0.048
-
Three synchronous HPV-associated squamous cell carcinomas of Waldeyer's ring: case report and comparison with Slaughter's model of field cancerization. Head Neck. 2010 Aug; 32(8):1118-24.
Score: 0.024
-
Measuring head and neck cancer symptom burden: the development and validation of the M. D. Anderson symptom inventory, head and neck module. Head Neck. 2007 Oct; 29(10):923-31.
Score: 0.020
-
A phase II study to assess the efficacy of amifostine for submandibular/sublingual salivary sparing during the treatment of head and neck cancer with intensity modulated radiation therapy for parotid salivary sparing. Semin Oncol. 2004 Dec; 31(6 Suppl 18):25-8.
Score: 0.016